Huasheng Lu
Cancer Research · 2002
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 11 citations into it; #1,019 of 1,780 by trust here, #1,310 by citations
Whom Huasheng Lu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Huasheng Lu overall
- V. Gogvadze
- D. Trachootham
- Robert A. Gatenby
- G. Brooks
- Robert James Gillies
- S. Orrenius
- Weiqin Lu
- Peggy P. Hsu
- J. Doherty
- N. Prabhakar
Papers from Huasheng Lu's perspective
Ordered by how strongly the researchers Huasheng Lu trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. (Genes & Development)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* (Journal of Biological Chemistry)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. (Journal of Clinical Investigation)
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth (Nature)
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. (Cancer Cell)
- HIF-1: mediator of physiological and pathophysiological responses to hypoxia. (Journal of applied physiology)
- Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression (Nature)